Malaria rarely mentioned in literary works has been dealt with by the two writers, both physicians, studied here. Louis-Ferdinand Destouches (1894-1961) alias Celine, studied medicine in Rennes and Paris from 1921 to 1924. He had been previously engaged by the Rockefeller Foundation to lecture on tuberculosis in Brittany. He later worked for the Commission of Hygiene of the League of Nations in Geneva and took part in 1925 to a long voyage in America (Cuba, United States) and Italy where malaria was still occurring. In 1926 he published a book: La quinine en therapeutique and participated to another voyage in West Africa where he contracted malaria. Numerous hints to this disease inspired to Celine by his first trip to Africa (Cameroun) in 1916-17 are found in Voyage au bout de la nuit (1932). Carlo Levi (1902-1975) studied medicine in Torino from 1919 to 1924. Painter and writer he wrote there his masterpiece: Christ has stopped in Eboli (1945). Malaria which then decimated a very poor population of peasants abandoned to themselves represents the background of the book and it is as a competent and human physician that C. Levi gained the friendship of the inhabitants of this remote and inhospitable province.

Download full-text PDF

Source

Publication Analysis

Top Keywords

studied medicine
8
[malaria work
4
work writer-physicians
4
writer-physicians louis
4
louis ferdinand
4
ferdinand celine
4
celine carlo
4
carlo levi]
4
malaria
4
levi] malaria
4

Similar Publications

Background: Insightful motion analysis provides valuable information for athlete health, a crucial aspect of sports medicine. This systematic review presents an analytical overview of the use of various sensors in motion analysis for sports injury assessment.

Methods: A comprehensive search of PubMed/MEDLINE, Scopus, and Web of Science was conducted in February 2024 using search terms related to "sport", "athlete", "sensor-based technology", "motion analysis", and "injury.

View Article and Find Full Text PDF

Background: Nephrotic syndrome (NS) is associated with an increased risk of venous thromboembolism (VTE). Anticoagulants are widely used in the prevention of VTE in NS patients. The use of direct oral anticoagulants (DOACs) has not been studied intensively in NS patients.

View Article and Find Full Text PDF

Background: Klebsiella pneumoniae is one of the most prevalent pathogens responsible for multiple infections in healthcare settings and the community. K. pneumoniae CG147, primarily including ST147 (the founder ST), ST273, and ST392, is one of the most globally successful MDR clone linked to various carbapenemases.

View Article and Find Full Text PDF

Background: Therapeutic antibodies for the treatment of neurological disease show great potential, but their applications are rather limited due to limited brain exposure. The most well-studied approach to enhance brain influx of protein therapeutics, is receptor-mediated transcytosis (RMT) by targeting nutrient receptors to shuttle protein therapeutics over the blood-brain barrier (BBB) along with their endogenous cargos. While higher brain exposure is achieved with RMT, the timeframe is short due to rather fast brain clearance.

View Article and Find Full Text PDF

Background: An appropriate clinical environment by providing learning opportunities, plays an important role in preparing students to apply the knowledge learned at the bedside. Since the lived experiences of patients in the clinical environment are effective on the quality of student's learning, the present study was conducted with the aim of explaining the lived experiences of patients regarding bedside teaching.

Materials And Methods: The present qualitative study was conducted using a content analysis approach in 2023 at the Imam Sajjad educational and therapeutic center affiliated with Tabriz Islamic Azad University of Medical Sciences.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!